Replies to post #83641 on Ayala Pharmaceuticals Inc (ADXS)

[hovacre]

Their data were alright. About what I would expect from an IO phase 1 trial at this stage. It's why I keep trying to chill everyone's expectations for the NEO phase 1 trial readout we hope to get by the end of 1H 2019; ours will likely not be much more explosive than this.